May 8, 2013
San Francisco-based HealthTap announced this week that it had raised $24 million in its second round of funding. Khosla Ventures led the investment with return backers Mayfield Fund and Mohr Davidow Ventures contributing, too. As part of the deal, Khosla Venture's Keith Rabois and former Square COO will join HealthTap's board of directors. Vinod Khosla will join as an advisor, too.
April 4, 2013
This week AliveCor, which offers the FDA-cleared iPhone-enabled Heart Monitor (formerly called the iPhoneECG), announced a new president and CEO: Dan Sullivan, a longtime medical device industry executive and entrepreneur. Sullivan sold his most recent venture, SuperDimension, to Covidien last year for more than $300 million. The company's first president and CEO, Judy Wade, who served in the...
March 26, 2013
Viewers of CNN's "The Next List," which Sunday featured Dr. Leslie Saxon and her Center for Body Computing at the University of Southern California, got both a lesson in what is possible in medicine today and a preview of what's coming in the near future.
The half-hour program highlighted some of the work Saxon, chief of cardiovascular medicine at USC's Keck School of Medicine, is doing at the...
March 20, 2013
Researchers at the University of California in San Francisco (UCSF) this week announced the launch of the Health eHeart Study, which is leveraging mobile health apps and connected consumer medical devices in an effort to track and monitor 1 million people in real-time. The study received significant attention this week thanks to a report in the Wall Street Journal (sub. req.). What's been largely...
March 18, 2013
Digital health innovators continue to make the national, mainstream media.
Dr. Leslie Saxon, director of the Center for Body Computing at the University of Southern California, will be profiled by Dr. Sanjay Gupta on Sunday's episode of CNN's "The Next List," which airs at 2:30 p.m. EDT. The show, hosted by CNN chief medical correspondent Gupta, explores innovation in science and technology.
March 12, 2013
Cardiac Designs' FDA-cleared ECG Check, not yet commercially available.
A new ECG device for the iPhone 4s called ECG Check received over-the-counter clearance from the FDA last month. The device, which would be the first product from Park City, Utah-based Cardiac Designs, appears very similar to the AliveCor Heart Monitor, which is currently only cleared for prescription use. The device was...
February 18, 2013
If there's one device that's recently become a symbol for the promise -- and potential pitfalls -- of mobile health, it's AliveCor Heart Monitor, formerly known as the AliveCor iPhone ECG, which received FDA clearance for prescription use in December. Dr. Dave Albert, AliveCor's chief medical officer, outlined some next moves for the company recently in response to an online conversation about...
December 3, 2012
The FDA has granted a 510(K) Class II clearance to San Francisco-based AliveCor's iPhone-enabled heart monitor, which has been commonly known as the "iPhoneECG" since it first made an appearance at CES two years ago. The company announced the clearance as the mHealth Summit kicks off this week in the Washington DC area. AliveCor will begin pre-selling the $199 clinical-quality, ECG monitor,...
November 28, 2012
Behavior monitoring and analytics startup Ginger.io has raised $6.5 million dollars in its first round of funding, led by increasingly frequent digital health investor Khosla Ventures. Existing investors from the company's $1.7 million seed round in October 2011, True Ventures and Romulus Capital, also contributed.
Ginger.io, which absorbed mobile health startup Pipette earlier this year, offers...
August 27, 2012
AliveCor, originator of the widely praised iPhone ECG, is going to the dogs – and cats and horses.
San Francisco-based AliveCor, founded by Oklahoma City cardiologist and entrepreneur Dr. David Albert, as of this month is marketing an iPhone-based veterinary heart monitor to veterinary health professionals and pet owners. In fact, since the human product has not received Food and Drug...